Diagnostic Accuracy of the Panbio Severe Acute Respiratory Syndrome Coronavirus 2 Antigen Rapid Test Compared with Reverse-Transcriptase Polymerase Chain Reaction Testing of Nasopharyngeal Samples in the Pediatric Population.
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 33484697.
- Also identified by DOI 10.1016/j.jpeds.2021.01.027 and PMC identifier 7826137.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
We conducted a multicenter clinical validity study of the Panbio coronavirus disease 2019 Antigen Rapid Test of nasopharyngeal samples in pediatric patients with coronavirus disease 2019-compatible symptoms of ≤5 days of evolution. Our study showed limited accuracy in nasopharyngeal antigen testing: overall sensitivity was 45.4%, and 99.8% of specificity, positive-predictive value was 92.5%.
Medical subject headings
- Antigens, Viral
- COVID-19
- DNA, Viral
- Nasopharynx
- Reverse Transcriptase Polymerase Chain Reaction
- SARS-CoV-2